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Abstract
To identify susceptibility loci for bipolar disorder, we tested 1.8 million variants in 4,387 cases
and 6,209 controls and identified a region of strong association (rs10994336, P = 9.1 × 10-9) in
ANK3 (ankyrin G). We also found further support for the previously reported CACNA1C (alpha
1C subunit of the L-type voltage-gated calcium channel; combined P = 7.0 × 10-8, rs1006737).
Our results suggest that ion channelopathies may be involved in the pathogenesis of bipolar
disorder.
Recent genome-wide association studies (GWAS) have identified genetic variants that show
consistent association with common, complex diseases, such as type 2 diabetes1, prostate
cancer2 and Crohn’s disease3. In many cases, a critical component for success involved
combining results and data across multiple, smaller studies to provide adequate power to
detect common variants of modest relative risk. Given that a single study will often not be
sufficient, here we present the results of combining two previously published4,5 and one
new (N 2,365) GWAS of bipolar disorder.
Three groups have performed independent GWAS of bipolar disorder, with little agreement
among the most associated regions. Baum et al.6, using DNA pooling, identified a SNP
located in DGKH (diacylglycerol kinase eta) that was associated with bipolar disorder in
1,233 cases and 1,439 controls with a P value of 1.5 × 10-8. The Wellcome Trust Case
Control Consortium (WTCCC)4 analyzedm 1,868 cases and 2,938 controls and identified a
locus in a gene-rich region of high linkage disequilibrium (LD) on chromosome 16p12 with
P = 6.3 × 10-8. Recently, Sklar et al.5 performed a GWAS of 1,461 cases and 2,008 controls
(the STEP-UCL study), finding the strongest single SNP result in MYO5B (myosin 5B),
with P = 1.7 × 10-7. Although there was no obvious correspondence among the studies’ top
few hits, a broader comparison of the WTCCC and STEP-UCL studies identified
CACNA1C as showing the strongest consistent signal5.
We genotyped a new sample of 1,098 individuals with bipolar disorder and 1,267 controls
on a similar platform as used by the WTCCC and STEP-UCL studies (Supplementary Table
1 online), with 331,786 SNPs passing quality control (Supplementary Methods online). This
dataset, referred to as ED-DUB-STEP2, included additional samples from the STEP-BD
study5 as well as cases and controls from the University of Edinburgh and Trinity College
Dublin. Approval for each study was obtained from the appropriate review boards of the
participating institutions and informed consent was obtained from all subjects. SNPs were
tested for association using logistic regression co-varying for sample collection site and
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quantitative indices of ancestry based on a multi-dimensional scaling analysis; the genomic
inflation factor (see Supplementary Methods) was λ1,000 = 1.056 (Supplementary Fig. 1
online).
Analysis of the ED-DUB-STEP2 samples identified 14 chromosomal regions associated at P
< 5 × 10-5 (Supplementary Table 2 online). No region exceeded our threshold × for genome-
wide significance of 5 × 10-8, correcting for an effective number of one million independent,
common SNPs in the genome1,7. However, one of these regions spanned the CACNA1C
association identified previously in the WTCCC and STEP-UCL studies5 (Supplementary
Fig. 2 online), thus providing further independent support that this gene is associated with
risk of bipolar disorder. In this region, the best single SNP across the WTCCC and STEP-
UCL studies showed a consistent association in ED-DUB-STEP2 (rs1006737, P = 0.011,
allele A, OR 1.21). Furthermore, the SNP with strongest association in ED-DUB-STEP2
(rs10774037, P = 4.6 × 10-5, allele G, OR 1.43) also had a consistent effect (P = 0.0008, OR
= 1.14) in the WTCCC and STEP-UCL samples and was in LD with rs1006737 (r2 = 0.39).
Next, we combined individual genotyping data=from the WTCCC, STEP-UCL and ED-
DUB-STEP2 studies, resulting in an overall sample of 4,387 cases and 6,209 controls
genotyped on 325,690 overlapping SNPs, which substantially improves power to detect risk
alleles of modest effect (Supplementary Table 1). The case sample comprised the following
diagnoses: 81% bipolar 1, 16% bipolar 2, 2% schizoaffective manic and 1% bipolar NOS
(Supplementary Table 3 online).
Genomic coverage was increased by imputing the genotypes for 1,444,258 additional
HapMap SNPs using PLINK8 (Supplementary Methods), resulting in a total set of
1,769,948 SNPs. Applying a leave-one-out procedure for every genotyped SNP, we
estimated concordance between imputed and true genotypes as 0.987 (Supplementary Table
4 online). Similar results were obtained using MACH1 (ref. 9; data not shown).
Our primary analysis was a logistic regression of disease state on single SNP allelic dosage,
either directly genotyped or imputed, controlling for study site and two quantitative indices
of ancestry (Supplementary Methods). The genomic inflation factor was λ1,000 = 1.024
when considering all SNPs, and λ1,000 = 1.021 for directly genotyped SNPs (Supplementary
Fig. 1 and Supplementary Fig. 3 online).
Results for the primary analysis are shown in Figure 1a and available for download (http://
pngu.mgh.harvard.edu/purcell/bpwgas2/). Thirty-nine SNPs showed a P < 10-6 and were
located in three distinct chromosomal regions (Table 1). An additional 18 regions had at
least one SNP with a P < 10-5 (Supplementary Fig. 4 and Supplementary Table 5 online).
Cluster plots for these SNPs are shown in Supplementary Figure 5 online.
The strongest association was in ANK3 on chromosome 10q21 for the imputed SNP
rs10994336, with P = 9.1 × 10-9 (Fig. 1b). This result was supported by the following
observations. First, multiple SNPs were associated across a 195-kb region. Second, three
genotyped SNPs showed P values similar to rs10994336 (for example, rs1938526, P = 1.3 ×
10-8, r2 = 0.40 with rs10994336). Third, haplotype analysis of genotyped SNPs supported
the single SNP results (most associated haplotype P 2.0 × 10-9, Supplementary Table 6
online). Fourth, the association remained (rs10994336, P = 5.2 × 10-9) after including the six
additional WTCCC disease panels as extra controls for the WTCCC dataset (‘expanded
reference group’ analysis). Finally, individual Sequenom genotyping confirmed that
rs10994336 was imputed with high accuracy (concordance = 0.983, N = 3,293).
The second strongest region of association was located in the third intron of CACNA1C on
chromosome 12p13 (rs1006737, P = 7.0 × 10-8). The third region was 3.3 kb away from an
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uncharacterized gene (C15orf53) on chromosome 15q14 (rs12899449, P = 3.5 × 10-7), in the
same LD block with the brain-expressed RASGRP1 (RAS guanyl releasing protein 1) gene.
The association with both regions remained in the expanded reference group analysis
(rs1006737, P = 4.0 × 10-8; rs12899449, P = 9.3 × 10-6).
Genotypic and heterogeneity analyses for these three regions suggested that the effect at
each locus was consistent with an additive model (Supplementary Table 7 online) and of
similar magnitude across studies (Supplementary Table 8 online). There was no clear
indication of differential association across bipolar subtypes, psychosis, age-at-onset and sex
(Supplementary Table 9 online). No significant treatment response effects were observed for
these three loci (data not shown).
Finally, we carried out a two-locus genome-wide search to identify epistatically acting loci
of moderate-to-large effect that single-locus analysis may have missed10,11. From over 4 ×
1010 pairwise tests, we identified 61 interactions with a P < 5 × 10-10, representing seven
distinct pairs of regions (Supplementary Table 10 online). No single interaction exceeded a
Bonferroni corrected-threshold of 1.2 × 10-12, in spite of reasonable power to detect large
interaction effects (Supplementary Methods).
In summary, we present evidence that variation in ANK3 confers risk of bipolar disorder in
three independent datasets. ANK3 is an adaptor protein found at axon initial segments that
has been shown to regulate the assembly of voltage-gated sodium channels12,13. We also
provide independent support that CACNA1C is associated with bipolar disorder. In addition,
we have recently shown that both ANK3 and subunits of the calcium channel are
downregulated in the mouse brain in response to lithium14, one the most effective bipolar
pharmacotherapies. Taken together, these results point to the possibility that bipolar disorder
is in part an ion channelopathy15.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Association results for the combined analysis of the WTCCC, STEP-UCL and ED-DUB-
STEP2 studies. (a) Genome-wide results (-log10P) are shown in chromosomal order for
directly genotyped (N = 325,690) and imputed (N = 1,444,258) SNPs that were tested for
association in the overall sample of 4,387 bipolar cases and 6,209 controls. Horizontal lines
indicate a P value of 5 × 10-8 (dashed) and 1 × 10-6 (dotted). (b) Plots for the three regions
of strongest association. Results (-log10P) are shown for directly genotyped (diamonds) and
imputed (circles) SNPs. The most associated SNP for each region is shown in blue, and the
color of the remaining markers reflects the linkage disequilibrium (r2) with the top SNP in
each panel (increasing red hue associated with increasing r2). The recombination rate
(second y axis) is plotted in light blue and is based on the CEU HapMap population. The
dashed horizontal line indicates a P = 5 × 10-8. Exons for each gene are represented by
vertical bars, based on all isoforms available from the Mar 2006 UCSC genome browser
assembly.
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